烧伤手术前苯丙胺阳性不 adverse 影响术中结局
研究比较两家烧伤中心对苯丙胺阳性患者手术时机的不同做法,共纳入270例患者。中心A仅在入院时筛查并据血流动力学和手术紧迫性手术,中心B每日筛查至阴性。调整烧伤严重度和住院至手术天数后,术中需血管活性药物支持与毒理学阴性结果无关(P=0.821),烧伤面积>20%显著增加血管活性药物支持风险(adj. OR 13.42 [3.90-46.23], P<0.001)。两中心死亡率、手术次数、卒中和住院时间相似。
要点
- 烧伤面积>20%与术中需血管活性药物支持显著相关(adj. OR 13.42 [3.90-46.23], P<0.001)。
- 术中需血管活性药物支持与术前毒理学阴性结果无关(P=0.821)。
- 等待苯丙胺毒理学阴性结果不影响术中管理或后续烧伤结局,系列毒理学检测无必要。
核心结论
- 比较两家认证烧伤中心表明,等待苯丙胺毒理学阴性结果不影响术中管理或后续烧伤结局。
- 系列毒理学检测对于指导苯丙胺使用烧伤患者的手术时机是不必要的。
研究设计与样本
- 研究纳入两家认证烧伤中心2017年至2022年间苯丙胺阳性烧伤患者共270例。
- 中心A仅在入院时获取毒理学检测,并根据血流动力学状态和手术紧迫性进行手术。
- 中心B每日送检毒理学直至结果阴性。
- 主要结局为指数手术期间血管活性药物的使用,采用逻辑回归调整烧伤严重度和住院至指数手术天数。
- 次要结局包括死亡和住院并发症。
主要发现
- 两中心人口统计学或烧伤特征无显著差异。
- 中心A筛查一次,中心B术前中位筛查四次。
- 术中需要血管活性药物支持的调整OR与毒理学阴性结果无关(P=0.821)。
- 烧伤体表面积>20%显著增加血管活性药物支持风险(adj. OR 13.42 [3.90-46.23], P<0.001)。
- 死亡率、手术次数、卒中和住院时间在队列间相似。
临床怎么用
- 作者结论认为,等待苯丙胺毒理学阴性结果不影响术中管理或后续烧伤结局。
- 作者结论认为,系列毒理学检测对于指导苯丙胺使用烧伤患者的手术时机是不必要的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The treatment of burn patients using amphetamines is challenging due hemodynamic liabilty and altered physiology. Wide variation exists in the operative timing for this patient population. We hypothesize that burn excision in patients admitted with amphetamine positivity is safe regardless of timing. Data from two verified burn centers between 2017 and 2022 with differing practice patterns in operative timing for amphetamine-positive patients. Center A obtains toxicology only on admission and proceeds with surgery based on hemodynamic status and operative urgency, whereas Center B sends daily toxicology until a negative test results. The primary outcome was the use of vasoactive agents during the index operation, modeled using logistic regression adjusting for burn severity and hospital days to index operation. Secondary outcomes included death and inpatient complications. A total of 270 patients were included, and there were no significant differences in demographics or burn characteristics between centers. Center A screened once and Center B obtained a median of four screens prior to the surgery. The adjusted OR of requiring vasoactive support intraoperatively was not associated with negative toxicology result (P = .821). Having a body surface area burned >20% conferred a significantly higher risk of vasoactive support (adj. OR 13.42 [3.90-46.23], P < .001). Mortality, number of operations, stroke, and hospital length of stay were similar between cohorts. Comparison between two verified burn centers indicates that waiting until a negative amphetamine toxicology result does not impact intraoperative management or subsequent burn outcomes. Serial toxicology tests are unnecessary to guide operative timing of burn patients with amphetamine use.
引用
- Rizk N, Crawford D, Karanas Y, et al. Amphetamine Positivity Prior to Burn Surgery Does not Adversely Affect Intraoperative Outcomes. J Burn Care Res. 2024. PMID: 37875155. doi:10.1093/jbcr/irad165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。